BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1272 related articles for article (PubMed ID: 33546185)

  • 1. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
    Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thapsigargin at Non-Cytotoxic Levels Induces a Potent Host Antiviral Response that Blocks Influenza A Virus Replication.
    Goulding LV; Yang J; Jiang Z; Zhang H; Lea D; Emes RD; Dottorini T; Pu J; Liu J; Chang KC
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
    Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
    Sourimant J; Lieber CM; Aggarwal M; Cox RM; Wolf JD; Yoon JJ; Toots M; Ye C; Sticher Z; Kolykhalov AA; Martinez-Sobrido L; Bluemling GR; Natchus MG; Painter GR; Plemper RK
    Science; 2022 Jan; 375(6577):161-167. PubMed ID: 34855509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
    Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.
    Drayman N; DeMarco JK; Jones KA; Azizi SA; Froggatt HM; Tan K; Maltseva NI; Chen S; Nicolaescu V; Dvorkin S; Furlong K; Kathayat RS; Firpo MR; Mastrodomenico V; Bruce EA; Schmidt MM; Jedrzejczak R; Muñoz-Alía MÁ; Schuster B; Nair V; Han KY; O'Brien A; Tomatsidou A; Meyer B; Vignuzzi M; Missiakas D; Botten JW; Brooke CB; Lee H; Baker SC; Mounce BC; Heaton NS; Severson WE; Palmer KE; Dickinson BC; Joachimiak A; Randall G; Tay S
    Science; 2021 Aug; 373(6557):931-936. PubMed ID: 34285133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication.
    Tripp RA; Martin DE
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germacrone inhibits early stages of influenza virus infection.
    Liao Q; Qian Z; Liu R; An L; Chen X
    Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
    Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.
    Zhao H; To KKW; Sze KH; Yung TT; Bian M; Lam H; Yeung ML; Li C; Chu H; Yuen KY
    Nat Commun; 2020 Aug; 11(1):4252. PubMed ID: 32843628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
    Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J
    Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
    Shen L; Niu J; Wang C; Huang B; Wang W; Zhu N; Deng Y; Wang H; Ye F; Cen S; Tan W
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Potential of Azelastine against Major Respiratory Viruses.
    Fischhuber K; Bánki Z; Kimpel J; Kragl N; Rössler A; Bolze A; Muellauer B; Angerer J; Nagy G; Nagy E; Szijarto V
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of bee venom and its components against viruses in vitro and in vivo.
    Uddin MB; Lee BH; Nikapitiya C; Kim JH; Kim TH; Lee HC; Kim CG; Lee JS; Kim CJ
    J Microbiol; 2016 Dec; 54(12):853-866. PubMed ID: 27888461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
    Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
    Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.
    Murray JL; McDonald NJ; Sheng J; Shaw MW; Hodge TW; Rubin DH; O'Brien WA; Smee DF
    Antivir Chem Chemother; 2012 May; 22(5):205-15. PubMed ID: 22374988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
    Arduino I; Francese R; Civra A; Feyles E; Argenziano M; Volante M; Cavalli R; Mougharbel AM; Kortz U; Donalisio M; Lembo D
    Antiviral Res; 2024 Jun; 226():105897. PubMed ID: 38685531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.